Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 0.28
CNMD's Cash to Debt is ranked higher than
52% of the 481 Companies
in the Global Medical Devices industry.

( Industry Median: 2.00 vs. CNMD: 0.28 )
CNMD' s 10-Year Cash to Debt Range
Min: 0   Max: No Debt
Current: 0.28

Equity to Asset 0.53
CNMD's Equity to Asset is ranked higher than
63% of the 451 Companies
in the Global Medical Devices industry.

( Industry Median: 0.64 vs. CNMD: 0.53 )
CNMD' s 10-Year Equity to Asset Range
Min: 0.29   Max: 0.93
Current: 0.53

0.29
0.93
Interest Coverage 8.64
CNMD's Interest Coverage is ranked higher than
51% of the 262 Companies
in the Global Medical Devices industry.

( Industry Median: 234.31 vs. CNMD: 8.64 )
CNMD' s 10-Year Interest Coverage Range
Min: 1.24   Max: 128
Current: 8.64

1.24
128
F-Score: 5
Z-Score: 3.28
M-Score: -2.72
WACC vs ROIC
10.17%
4.98%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 7.13
CNMD's Operating margin (%) is ranked higher than
78% of the 465 Companies
in the Global Medical Devices industry.

( Industry Median: 5.96 vs. CNMD: 7.13 )
CNMD' s 10-Year Operating margin (%) Range
Min: -0.71   Max: 20.38
Current: 7.13

-0.71
20.38
Net-margin (%) 4.35
CNMD's Net-margin (%) is ranked higher than
75% of the 465 Companies
in the Global Medical Devices industry.

( Industry Median: 4.35 vs. CNMD: 4.35 )
CNMD' s 10-Year Net-margin (%) Range
Min: -5.13   Max: 12.98
Current: 4.35

-5.13
12.98
ROE (%) 5.41
CNMD's ROE (%) is ranked higher than
75% of the 450 Companies
in the Global Medical Devices industry.

( Industry Median: 5.07 vs. CNMD: 5.41 )
CNMD' s 10-Year ROE (%) Range
Min: -4.42   Max: 13.96
Current: 5.41

-4.42
13.96
ROA (%) 2.94
CNMD's ROA (%) is ranked higher than
74% of the 481 Companies
in the Global Medical Devices industry.

( Industry Median: 2.23 vs. CNMD: 2.94 )
CNMD' s 10-Year ROA (%) Range
Min: -1.94   Max: 11.26
Current: 2.94

-1.94
11.26
ROC (Joel Greenblatt) (%) 15.30
CNMD's ROC (Joel Greenblatt) (%) is ranked higher than
80% of the 479 Companies
in the Global Medical Devices industry.

( Industry Median: 8.65 vs. CNMD: 15.30 )
CNMD' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -1.56   Max: 70.82
Current: 15.3

-1.56
70.82
Revenue Growth (3Y)(%) 1.70
CNMD's Revenue Growth (3Y)(%) is ranked higher than
72% of the 345 Companies
in the Global Medical Devices industry.

( Industry Median: 5.00 vs. CNMD: 1.70 )
CNMD' s 10-Year Revenue Growth (3Y)(%) Range
Min: -0.1   Max: 40.6
Current: 1.7

-0.1
40.6
EBITDA Growth (3Y)(%) 33.00
CNMD's EBITDA Growth (3Y)(%) is ranked higher than
80% of the 310 Companies
in the Global Medical Devices industry.

( Industry Median: 2.80 vs. CNMD: 33.00 )
CNMD' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -35.8   Max: 43.1
Current: 33

-35.8
43.1
EPS Growth (3Y)(%) 238.20
CNMD's EPS Growth (3Y)(%) is ranked higher than
80% of the 311 Companies
in the Global Medical Devices industry.

( Industry Median: 2.20 vs. CNMD: 238.20 )
CNMD' s 10-Year EPS Growth (3Y)(%) Range
Min: -73   Max: 238.2
Current: 238.2

-73
238.2
» CNMD's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2014

CNMD Guru Trades in Q1 2014

Steven Cohen 14,110 sh (New)
Jim Simons 45,681 sh (New)
Joel Greenblatt 13,467 sh (New)
Paul Tudor Jones 24,923 sh (+241.41%)
John Keeley 54,620 sh (unchged)
Chuck Royce 82,200 sh (unchged)
Mario Gabelli 93,000 sh (-0.21%)
Ken Fisher 67,300 sh (-9.3%)
» More
Q2 2014

CNMD Guru Trades in Q2 2014

Joel Greenblatt 168,447 sh (+1150.81%)
Jim Simons 210,760 sh (+361.37%)
Chuck Royce 82,200 sh (unchged)
Steven Cohen 27,100 sh (unchged)
Ken Fisher 67,300 sh (unchged)
Mario Gabelli 92,300 sh (-0.75%)
Paul Tudor Jones 22,370 sh (-10.24%)
John Keeley 34,641 sh (-36.58%)
» More
Q3 2014

CNMD Guru Trades in Q3 2014

Ken Fisher 413,810 sh (+514.87%)
Paul Tudor Jones 24,642 sh (+10.16%)
Chuck Royce 82,200 sh (unchged)
John Keeley 34,641 sh (unchged)
Joel Greenblatt Sold Out
Steven Cohen Sold Out
Mario Gabelli 92,100 sh (-0.22%)
Jim Simons 180,481 sh (-14.37%)
» More
Q4 2014

CNMD Guru Trades in Q4 2014

Chuck Royce 82,200 sh (unchged)
Jim Simons Sold Out
Mario Gabelli 91,700 sh (-0.43%)
Ken Fisher 405,705 sh (-1.96%)
John Keeley 33,341 sh (-3.75%)
Paul Tudor Jones 8,180 sh (-66.8%)
» More
» Details

Insider Trades

Latest Guru Trades with CNMD

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2014-09-30 Sold Out 0.09%$36.53 - $45.36 $ 51.330%0
Ken Fisher 2014-09-30 Add 514.87%0.03%$36.53 - $45.36 $ 51.330%413810
Joel Greenblatt 2014-06-30 Add 1150.81%0.09%$42.23 - $49.65 $ 51.313%168447
John Keeley 2014-06-30 Reduce -36.58%0.01%$42.23 - $49.65 $ 51.313%34641
Joel Greenblatt 2014-03-31 New Buy0.01%$41.33 - $48.54 $ 51.315%13467
Joel Greenblatt 2013-12-31 Sold Out 0.02%$33.25 - $42.48 $ 51.335%0
John Keeley 2013-12-31 Reduce -23.9%0.01%$33.25 - $42.48 $ 51.335%54620
Joel Greenblatt 2013-09-30 Reduce -61.01%0.04%$31.07 - $33.76 $ 51.357%19019
Joel Greenblatt 2013-06-30 Reduce -41.34%0.06%$30.42 - $34.04 $ 51.358%48778
John Keeley 2013-06-30 Add 43.21%0.01%$30.42 - $34.04 $ 51.358%63970
John Keeley 2013-03-31 Add 27.74%0.01%$27.95 - $34.29 $ 51.370%44670
Ken Fisher 2013-03-31 Add 39.12%$27.95 - $34.29 $ 51.370%91400
John Keeley 2012-12-31 New Buy0.02%$25.71 - $29.33 $ 51.386%34970
Ken Fisher 2012-06-30 Add 65.49%$26.01 - $30.27 $ 51.383%65700
Joel Greenblatt 2012-03-31 Add 39.72%0.04%$26.44 - $30.47 $ 51.390%57083
Richard Pzena 2012-03-31 Sold Out 0.01%$26.44 - $30.47 $ 51.390%0
Ken Fisher 2012-03-31 New Buy$26.44 - $30.47 $ 51.390%39700
Richard Pzena 2011-12-31 Reduce -87.21%0.09%$21.72 - $27.83 $ 51.3101%49272
Joel Greenblatt 2011-12-31 Add 53.81%0.05%$21.72 - $27.83 $ 51.3101%40854
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 44.30
CNMD's P/E(ttm) is ranked higher than
79% of the 525 Companies
in the Global Medical Devices industry.

( Industry Median: 98.30 vs. CNMD: 44.30 )
CNMD' s 10-Year P/E(ttm) Range
Min: 8.88   Max: 755.25
Current: 44.3

8.88
755.25
Forward P/E 21.69
CNMD's Forward P/E is ranked higher than
89% of the 525 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. CNMD: 21.69 )
N/A
PE(NRI) 44.20
CNMD's PE(NRI) is ranked higher than
78% of the 525 Companies
in the Global Medical Devices industry.

( Industry Median: 80.70 vs. CNMD: 44.20 )
CNMD' s 10-Year PE(NRI) Range
Min: 8.88   Max: 755.25
Current: 44.2

8.88
755.25
P/B 2.43
CNMD's P/B is ranked higher than
81% of the 525 Companies
in the Global Medical Devices industry.

( Industry Median: 4.20 vs. CNMD: 2.43 )
CNMD' s 10-Year P/B Range
Min: 0.61   Max: 2.43
Current: 2.43

0.61
2.43
P/S 1.92
CNMD's P/S is ranked higher than
81% of the 525 Companies
in the Global Medical Devices industry.

( Industry Median: 3.74 vs. CNMD: 1.92 )
CNMD' s 10-Year P/S Range
Min: 0.48   Max: 1.92
Current: 1.92

0.48
1.92
PFCF 28.50
CNMD's PFCF is ranked higher than
89% of the 525 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. CNMD: 28.50 )
CNMD' s 10-Year PFCF Range
Min: 7.44   Max: 2046
Current: 28.5

7.44
2046
POCF 21.92
CNMD's POCF is ranked higher than
83% of the 525 Companies
in the Global Medical Devices industry.

( Industry Median: 73.76 vs. CNMD: 21.92 )
CNMD' s 10-Year POCF Range
Min: 6.18   Max: 138.5
Current: 21.92

6.18
138.5
EV-to-EBIT 30.11
CNMD's EV-to-EBIT is ranked higher than
80% of the 525 Companies
in the Global Medical Devices industry.

( Industry Median: 67.21 vs. CNMD: 30.11 )
CNMD' s 10-Year EV-to-EBIT Range
Min: -226.3   Max: 153.1
Current: 30.11

-226.3
153.1
PEG 3.65
CNMD's PEG is ranked higher than
94% of the 525 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. CNMD: 3.65 )
CNMD' s 10-Year PEG Range
Min: 1.23   Max: 210.83
Current: 3.65

1.23
210.83
Shiller P/E 56.70
CNMD's Shiller P/E is ranked higher than
86% of the 525 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. CNMD: 56.70 )
CNMD' s 10-Year Shiller P/E Range
Min: 11.93   Max: 56.96
Current: 56.7

11.93
56.96
Current Ratio 3.29
CNMD's Current Ratio is ranked higher than
76% of the 473 Companies
in the Global Medical Devices industry.

( Industry Median: 2.59 vs. CNMD: 3.29 )
CNMD' s 10-Year Current Ratio Range
Min: 1.37   Max: 12.38
Current: 3.29

1.37
12.38
Quick Ratio 2.01
CNMD's Quick Ratio is ranked higher than
69% of the 473 Companies
in the Global Medical Devices industry.

( Industry Median: 1.98 vs. CNMD: 2.01 )
CNMD' s 10-Year Quick Ratio Range
Min: 0.48   Max: 8.38
Current: 2.01

0.48
8.38
Days Inventory 165.69
CNMD's Days Inventory is ranked higher than
69% of the 525 Companies
in the Global Medical Devices industry.

( Industry Median: 158.55 vs. CNMD: 165.69 )
CNMD' s 10-Year Days Inventory Range
Min: 136.41   Max: 231.38
Current: 165.69

136.41
231.38
Days Sales Outstanding 63.77
CNMD's Days Sales Outstanding is ranked higher than
80% of the 525 Companies
in the Global Medical Devices industry.

( Industry Median: 78.72 vs. CNMD: 63.77 )
CNMD' s 10-Year Days Sales Outstanding Range
Min: 42.39   Max: 125.1
Current: 63.77

42.39
125.1

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.56
CNMD's Dividend Yield is ranked higher than
57% of the 189 Companies
in the Global Medical Devices industry.

( Industry Median: 1.45 vs. CNMD: 1.56 )
CNMD' s 10-Year Dividend Yield Range
Min: 0.5   Max: 2.22
Current: 1.56

0.5
2.22
Dividend Payout 0.69
CNMD's Dividend Payout is ranked higher than
80% of the 525 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. CNMD: 0.69 )
CNMD' s 10-Year Dividend Payout Range
Min: 0.43   Max: 0.69
Current: 0.69

0.43
0.69
Yield on cost (5-Year) 1.50
CNMD's Yield on cost (5-Year) is ranked higher than
52% of the 191 Companies
in the Global Medical Devices industry.

( Industry Median: 1.60 vs. CNMD: 1.50 )
CNMD' s 10-Year Yield on cost (5-Year) Range
Min: 0.5   Max: 2.22
Current: 1.5

0.5
2.22
Share Buyback Rate 1.00
CNMD's Share Buyback Rate is ranked higher than
92% of the 333 Companies
in the Global Medical Devices industry.

( Industry Median: -1.30 vs. CNMD: 1.00 )
CNMD' s 10-Year Share Buyback Rate Range
Min: 1.6   Max: -9.7
Current: 1

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 165.48
CNMD's Price/Tangible Book is ranked higher than
57% of the 525 Companies
in the Global Medical Devices industry.

( Industry Median: 8.78 vs. CNMD: 165.48 )
CNMD' s 10-Year Price/Tangible Book Range
Min: 3.39   Max: 145.06
Current: 165.48

3.39
145.06
Price/DCF (Projected) 1.52
CNMD's Price/DCF (Projected) is ranked higher than
94% of the 525 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. CNMD: 1.52 )
CNMD' s 10-Year Price/DCF (Projected) Range
Min: 0.78   Max: 1.33
Current: 1.52

0.78
1.33
Price/Median PS Value 1.73
CNMD's Price/Median PS Value is ranked higher than
64% of the 525 Companies
in the Global Medical Devices industry.

( Industry Median: 1.32 vs. CNMD: 1.73 )
CNMD' s 10-Year Price/Median PS Value Range
Min: 0.61   Max: 2.62
Current: 1.73

0.61
2.62
Price/Peter Lynch Fair Value 4.92
CNMD's Price/Peter Lynch Fair Value is ranked higher than
95% of the 525 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. CNMD: 4.92 )
CNMD' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.55   Max: 5.89
Current: 4.92

0.55
5.89
Price/Graham Number 17.88
CNMD's Price/Graham Number is ranked higher than
76% of the 525 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. CNMD: 17.88 )
CNMD' s 10-Year Price/Graham Number Range
Min: 1.65   Max: 15.67
Current: 17.88

1.65
15.67
Earnings Yield (Greenblatt) 3.30
CNMD's Earnings Yield (Greenblatt) is ranked higher than
79% of the 477 Companies
in the Global Medical Devices industry.

( Industry Median: 2.30 vs. CNMD: 3.30 )
CNMD' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.7   Max: 13.1
Current: 3.3

0.7
13.1
Forward Rate of Return (Yacktman) 13.04
CNMD's Forward Rate of Return (Yacktman) is ranked higher than
87% of the 218 Companies
in the Global Medical Devices industry.

( Industry Median: 5.16 vs. CNMD: 13.04 )
CNMD' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -13.9   Max: 21.2
Current: 13.04

-13.9
21.2

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Traded in other countries:EC8.Germany,
Conmed Corp was incorporated under the laws of the State of New York in 1970. It is a medical technology company with an emphasis on surgical devices and equipment for minimally invasive procedures and monitoring. The Company's products serve the clinical areas, surgeons and physicians in a variety of specialties including orthopedics, general surgery, gynecology, neurosurgery, and gastroenterology. Effective January 1, 2013, the Company is accounting and reporting business as a single segment entity engaged in the development, manufacturing and sale on a basis of surgical devices and related equipment. The business is derived from sales in orthopedic surgery product lines, including sports medicine, powered surgical instruments and sports biologics and tissue. These lines are marketed under a number of reputable brands, including Hall, CONMED Linvatec, Concept and Shutt. The surgical visualization product line offers endoscopic imaging and capture devices for the complete spectrum of surgical needs including 2DHD and 3DHD vision technologies. The general surgery product line offers in the areas of advanced energy, endomechanical instrumentation, gastrointestinal, pulmonary and patient monitoring. The products are distributed domestically directly to more than 6,000 hospitals and other healthcare institutions as well as through medical specialty distributors and surgeons. The operation of Company are subject, to a number of environmental laws and regulations governing, among other things, air emissions, wastewater discharges, the use, handling and disposal of hazardous substances and wastes, soil and groundwater remediation and employee health and safety.
» More Articles for CNMD

Headlines

Articles On GuruFocus.com
CONMED Corporation Announces Preliminary 2014 Results Within Guidance Range and Issues 2015 Financia Jan 14 2015 
CONMED Corporation to Announce Fourth Quarter 2014 Financial Results on January 27, 2015 Jan 08 2015 
CONMED Corporation to Present at the 33rd Annual J.P. Morgan Healthcare Conference Dec 11 2014 
CONMED Corporation to Announce Third Quarter 2014 Financial Results on October 23, 2014 Oct 15 2014 
Paulson, Mindich and Soros Bought Covidien; Should You? Sep 11 2014 
Weekly CEO Buys Highlight: APD, OCUL, CNMD, OPK, AEGR Aug 04 2014 
Weekly CEO Sells Highlight: Profire energy Inc, Graphic Packaging Holding Co, Seagate Technology PLC Aug 04 2014 
My 5 Favorite High Beta Health Care Dividend Stocks Aug 02 2013 
CONMED Corp. (CNMD) Vice President/Finance/CFO Robert D Jr Shallish sells 6,151 Shares Feb 07 2011 
CONMED Corp. Reports Operating Results (10-Q) Nov 02 2010 

More From Our Partners
Zacks Rank #5 Additions for Tuesday - Tale of the Tape Feb 24 2015 - ZACKS

More From Other Websites
CONMED (CNMD) is in Overbought Territory: What's Next? - Tale of the Tape Feb 26 2015
10-K for CONMED Corp. Feb 25 2015
CONMED CORP Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial... Feb 25 2015
CONMED Corporation Announces Quarterly Cash Dividend Feb 25 2015
CONMED Corporation Announces Quarterly Cash Dividend Feb 25 2015
Zacks Rank #5 Additions for Tuesday - Tale of the Tape Feb 24 2015
CONMED CORP Files SEC form 10-K, Annual Report Feb 23 2015
CONMED Corporation to Present at the 2015 Leerink Global Healthcare Conference Feb 04 2015
CONMED Corporation to Present at the 2015 Leerink Global Healthcare Conference Feb 04 2015
CONMED Q4 Earnings Flat but Revenues Down, '15 View Cut - Analyst Blog Jan 28 2015
CONMED CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Jan 28 2015
Conmed posts 4Q profit Jan 27 2015
Conmed posts 4Q profit Jan 27 2015
Conmed Corp Earnings Call scheduled for 4:30 pm ET today Jan 27 2015
CONMED Corporation Announces Fourth Quarter and Full Year 2014 Financial Results Jan 27 2015
Q4 2014 Conmed Corp Earnings Release - 4:00 pm ET Jan 27 2015
CONMED Announces Preliminary FY14 Results, Guides FY15 - Analyst Blog Jan 15 2015
CONMED CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Jan 14 2015
CONMED Corporation Announces Preliminary 2014 Results Within Guidance Range and Issues 2015... Jan 14 2015
CONMED Corporation Announces Preliminary 2014 Results Within Guidance Range and Issues 2015... Jan 14 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK